Pinnacle Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-326
| Closed | -$8.71K | – | 901 |
|
|
2024
Q3 | $8.71K | Sell |
326
-1,267
| -80% | -$33.9K | ﹤0.01% | 799 |
|
|
2024
Q2 | $14.8K | Buy |
+1,593
| New | +$14.8K | ﹤0.01% | 812 |
|
|
2024
Q1 | – | Sell |
-326
| Closed | -$8.71K | – | 850 |
|
|
2023
Q4 | $8.71K | Sell |
326
-17,709
| -98% | -$473K | ﹤0.01% | 815 |
|
|
2023
Q3 | $1.09M | Sell |
18,035
-644
| -3% | -$38.9K | 0.02% | 444 |
|
|
2023
Q2 | $1.9M | Sell |
18,679
-194
| -1% | -$19.8K | 0.03% | 366 |
|
|
2023
Q1 | $3.34M | Sell |
18,873
-235
| -1% | -$41.5K | 0.07% | 245 |
|
|
2022
Q4 | $7.39M | Sell |
19,108
-486
| -2% | -$188K | 0.16% | 155 |
|
|
2022
Q3 | $6.6M | Sell |
19,594
-1,037
| -5% | -$349K | 0.15% | 162 |
|
|
2022
Q2 | $6.78M | Buy |
20,631
+72
| +0.4% | +$23.7K | 0.15% | 165 |
|
|
2022
Q1 | $8.99M | Buy |
20,559
+9,935
| +94% | +$4.35M | 0.16% | 159 |
|
|
2021
Q4 | $4.66M | Buy |
10,624
+1,209
| +13% | +$530K | 0.08% | 225 |
|
|
2021
Q3 | $5.24M | Sell |
9,415
-296
| -3% | -$165K | 0.1% | 214 |
|
|
2021
Q2 | $4.99M | Buy |
9,711
+137
| +1% | +$70.4K | 0.09% | 219 |
|
|
2021
Q1 | $7.48M | Sell |
9,574
-789
| -8% | -$617K | 0.14% | 164 |
|
|
2020
Q4 | $5.65M | Sell |
10,363
-780
| -7% | -$425K | 0.11% | 184 |
|
|
2020
Q3 | $5.11M | Sell |
11,143
-333
| -3% | -$153K | 0.12% | 180 |
|
|
2020
Q2 | $7.06M | Sell |
11,476
-134
| -1% | -$82.5K | 0.17% | 142 |
|
|
2020
Q1 | $5.52M | Sell |
11,610
-1,332
| -10% | -$633K | 0.17% | 144 |
|
|
2019
Q4 | $7.51M | Buy |
12,942
+3,279
| +34% | +$1.9M | 0.16% | 155 |
|
|
2019
Q3 | $6.36M | Buy |
+9,663
| New | +$6.36M | 0.15% | 165 |
|